The propagation of genetic polymorphism in CYP2C9 into warfarin pharmacokinetics: An integrated model

被引：0
|
作者：
Dickinson, GL [1 ]
Lennard, MS [1 ]
Tucker, GT [1 ]
Rostami-Hodjegan, A [1 ]
机构：
[1] Univ Sheffield, Acad Unit Clin Pharmacol, Sheffield, S Yorkshire, England
来源：
DRUG METABOLISM REVIEWS | 2005年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
74
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [41] The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variations
    Kirac, Deniz
    Yaman, Aysun Erdem
    Doran, Tansu
    Altunok, Elif Cigdem
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 209 - 213
  • [42] Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans
    Hernandez, Wenndy
    Aquino-Michaels, Keston
    Drozda, Katarzyna
    Patel, Shitalban
    Jeong, Young
    Takahashi, Harumi
    Cavallari, Larisa H.
    Perera, Minoli A.
    TRANSLATIONAL RESEARCH, 2015, 165 (06) : 651 - 657
  • [43] Genetic association between sensitivity to warfarin and expression of CYP2C9*3
    Steward, DJ
    Haining, RL
    Henne, KR
    Davis, G
    Rushmore, TH
    Trager, WF
    Rettie, AE
    PHARMACOGENETICS, 1997, 7 (05): : 361 - 367
  • [44] CYP2C9 Genotype-DependentWarfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R-and S-Warfarin and Their Oxidative Metabolites
    Flora, Darcy R.
    Rettie, Allan E.
    Brundage, Richard C.
    Tracy, Timothy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (03): : 382 - 393
  • [45] The genetic analysis of CYP2C9 polymorphism in a Korean population.
    Yoon, YR
    Shon, JH
    Lee, HR
    Cha, IJ
    Shin, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 184 - 184
  • [46] Effects of CYP2C9 and MDR1 polymorphism on the pharmacokinetics of losartan
    Bae, Jung-Woo
    Han, Ho-Kyun
    Lee, Hwan-Joo
    Jung, Dong -Won
    Kim, Nam-Tae
    Lee, Jin-Hee
    Jang, Choon-Gon
    Choi, Sun-Ok
    Kim, Ok-Hee
    Lee, Seok-Yong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 230 - 231
  • [47] Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects
    Kim, Mi-Jung
    Bae, Jung -Woo
    Han, Ho-Kyun
    Choi, Sun-Ok
    Kim, Ok-Hee
    Jang, Choon-Gon
    Lee, Jin-Hee
    Kim, Nam-Tae
    Lee, Seok-Yong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 231 - 231
  • [48] Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro
    Wang, Li
    Bao, Shi-Hui
    Pan, Pei-Pei
    Xia, Meng-Ming
    Chen, Meng-Chun
    Liang, Bing-Qing
    Dai, Da-Peng
    Cai, Jian-Ping
    Hu, Guo-Xin
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (08) : 1363 - 1367
  • [49] CYP2C9 genetic polymorphism in an African American population.
    Jackson, MD
    Macpherson, AS
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 219 - 219
  • [50] Mutations of the CYP2C9 gene and the response to warfarin
    Yasar, U
    Oscarson, M
    Eliasson, E
    Sjöqvist, F
    SURGERY, 2001, 129 (03) : 384 - 384
12345